FDA Inspection 1198364 — Centaur Pharmaceuticals Private Ltd.
The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on February 8, 2023 in Pune. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pune (India)